🟢 Tempus AI Jumps 10.35% on Piper Sandler Upgrade, Personalis Acquisition Optimism, and Strong Q2 Results

Tempus AI is trading 10.35% up now at $68.65, driven by several key catalysts today:

• Piper Sandler upgraded Tempus AI to Overweight, raising its price target to $76 (from $56), citing optimism around the Personalis acquisition and encouraging clinical data.
• Positive sentiment surrounds the strategic ~$1.5B Personalis acquisition, which aims to deepen Tempus AI's tumor-informed molecular residual disease (MRD) and sequencing capabilities.
• Strong Q2 2026 financial results were reported, including 22% year-over-year revenue growth to $382.5 million, and a shift to positive net income and EBITDA.
• At the Morgan Stanley conference, management emphasized durable diagnostics demand and expanding data licensing, citing approximately 36% data-licensing growth and three consecutive quarters exceeding $100 million in total contract value.